LCTA-3344

N/A

Report date: 2025/01/26 19:10:10
NME

Base Information

Drug NameLCTA-3344
Drug Alias Nameandrogen receptor antagonist (N.N. Blokhin National Medical Research Center of Oncology/Gause institute of new antibiotics)LCTA-3344
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN.N. Blokhin National Medical Research Center Of Oncology
China Registration ClassN/A

Develop Information

Active CompaniesN.N. Blokhin National Medical Research Center Of Oncology
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A